M K Proteins appoints Aritika Garg as independent director
- M K Proteins appointed Ms. Aritika Garg as an additional independent director on August 22, 2026
- The Chartered Accountant has over 15 years of experience in finance, audit, and taxation
- Her five-year tenure is subject to approval by shareholders at the upcoming AGM
- She holds no other listed directorships and has no relationship with existing board members

*this image is generated using AI for illustrative purposes only.
M K Proteins has appointed Ms. Aritika Garg as an additional independent director on its Board of Directors. The appointment was approved during the company’s board meeting held on August 22, 2026.
Ms. Garg, a qualified Chartered Accountant with over 15 years of experience, will serve in the capacity of a Non-Executive Independent Director. Her appointment is subject to the approval of members at the company’s ensuing Annual General Meeting (AGM).
Director Profile
Ms. Garg possesses professional expertise in accounting, finance, taxation, audit, and related corporate matters. The board determined that her knowledge and skills are relevant for discharging the responsibilities of an Independent Director.
| Particulars | Details |
|---|---|
| Name & DIN | Ms. Aritika Garg (DIN: 11895058) |
| Appointment Date | August 22, 2026 |
| Tenure | Five years, subject to shareholder approval |
| Other Listed Directorships | Nil |
| Relationship with Existing Directors | None |
The disclosure confirms that Ms. Garg is not related to any existing directors on the board. She is not debarred from holding the office of director by virtue of any SEBI order or other regulatory authority.
Regulatory Compliance
The appointment aligns with Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board meeting commenced at 3:00 pm and concluded at 3:30 pm on August 22, 2026.
Historical Stock Returns for MK Proteins
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.24% | -0.96% | -3.73% | -21.18% | -38.36% | +48.56% |
How might Ms. Garg's expertise in taxation and audit influence MK Proteins' financial reporting strategies or regulatory compliance posture in the coming fiscal year?
What specific governance reforms or strategic initiatives is the board likely to prioritize with the addition of an independent director possessing this specific professional background?
Given that the appointment is subject to AGM approval, are there any indications of shareholder sentiment or potential dissent regarding board composition changes?


































